Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
1999 2
2000 2
2001 2
2002 2
2004 1
2005 1
2006 1
2009 1
2010 1
2011 1
2013 2
2016 1
2017 2
2018 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Bone management in hematologic stem cell transplant recipients.
Kendler DL, Body JJ, Brandi ML, Broady R, Cannata-Andia J, Cannata-Ortiz MJ, El Maghraoui A, Guglielmi G, Hadji P, Pierroz DD, de Villiers TJ, Rizzoli R, Ebeling PR; International Osteoporosis Foundation Committee of Scientific Advisors Working Group on Cancer and Bone Disease. Kendler DL, et al. Osteoporos Int. 2018 Dec;29(12):2597-2610. doi: 10.1007/s00198-018-4669-4. Epub 2018 Sep 3. Osteoporos Int. 2018. PMID: 30178158 Review.
Hypogonadism, HSCT preparative regimens, nutritional factors, and glucocorticoids all contribute to accelerated bone loss and increased fracture risk. ...Evidence has accumulated permitting recommendations for more attentiveness to evaluation and monitoring o …
Hypogonadism, HSCT preparative regimens, nutritional factors, and glucocorticoids all contribute to accelerated bone loss and …
Prevention of bone loss and fracture after lung transplantation: a pilot study.
Cahill BC, O'Rourke MK, Parker S, Stringham JC, Karwande SV, Knecht TP. Cahill BC, et al. Transplantation. 2001 Oct 15;72(7):1251-5. doi: 10.1097/00007890-200110150-00012. Transplantation. 2001. PMID: 11602851 Clinical Trial.
Radiologic evaluation was performed for clinical suspicion of fracture. Bone density was remeasured 1 year after transplantation. ...CONCLUSIONS: Antiresorptive therapy with a bisphosphonate decreases the fracture rate and preserves bo …
Radiologic evaluation was performed for clinical suspicion of fracture. Bone density was remeasured 1 year after tra …
Osteoporosis after organ transplantation.
Rodino MA, Shane E. Rodino MA, et al. Am J Med. 1998 May;104(5):459-69. doi: 10.1016/s0002-9343(98)00081-3. Am J Med. 1998. PMID: 9626030 Free article. Review.
Rates of bone loss and fracture are greatest during the first 6 to 12 months after transplantation. ...Therapy for osteoporosis, low bone mass, and potentially reversible biochemical causes of bone loss should be instituted during …
Rates of bone loss and fracture are greatest during the first 6 to 12 months after transplantation. ...Therapy f …
GLUCOCORTICOID EXCESS IN BONE AND MUSCLE.
Sato AY, Peacock M, Bellido T. Sato AY, et al. Clin Rev Bone Miner Metab. 2018 Mar;16(1):33-47. doi: 10.1007/s12018-018-9242-3. Epub 2018 Feb 5. Clin Rev Bone Miner Metab. 2018. PMID: 29962904 Free PMC article.
Because of their profound immunosuppressive and anti-inflammatory actions, GC are extensively used for the treatment of immune and inflammatory conditions, the management of organ transplantation, and as a component of chemotherapy regimens for cancers. ...In …
Because of their profound immunosuppressive and anti-inflammatory actions, GC are extensively used for the treatment of immune and inflammat …
Bisphosphonates for the prevention and treatment of corticosteroid-induced osteoporosis.
Miller PD. Miller PD. Osteoporos Int. 2001 Dec;12 Suppl 3:S3-10. doi: 10.1007/pl00014038. Osteoporos Int. 2001. PMID: 11846338 Review.
The clinical trial data reviewed here demonstrate that bisphosphonate therapy can reverse, at least in part, established corticosteroid-induced osteoporosis, increase BMD, and prevent the development of new fractures. ...Bisphosphonate therapy, …
The clinical trial data reviewed here demonstrate that bisphosphonate therapy can reverse, at least in part, established corti …
Lack of effect of intravenous pamidronate on fracture incidence and bone mineral density after orthotopic liver transplantation.
Ninkovic M, Love S, Tom BD, Bearcroft PW, Alexander GJ, Compston JE. Ninkovic M, et al. J Hepatol. 2002 Jul;37(1):93-100. doi: 10.1016/s0168-8278(02)00100-9. J Hepatol. 2002. PMID: 12076867 Clinical Trial.
BACKGROUND/AIMS: Increased rates of bone loss and fracture have been reported after liver transplantation. ...The low incidence of fracture and absence of spinal bone loss indicate that bone disease after liver transplantation may …
BACKGROUND/AIMS: Increased rates of bone loss and fracture have been reported after liver transplantation. ...The low i …
[Post-transplantation osteoporosis].
Negri AL, Plantalech LC, Russo Picasso MF, Otero A, Sarli M. Negri AL, et al. Medicina (B Aires). 1999;59(6):777-86. Medicina (B Aires). 1999. PMID: 10752228 Review. Spanish.
These effects are superimposed on the previous bone lesions produced by the underlying chronic diseases. Rapid bone loss occurs specially during the first 6 to 12 months after transplantation, when the incidence of fractures is greater. ...The most pro …
These effects are superimposed on the previous bone lesions produced by the underlying chronic diseases. Rapid bone loss occur …
Mechanisms of osteoporosis after hematopoietic cell transplantation.
Weilbaecher KN. Weilbaecher KN. Biol Blood Marrow Transplant. 2000;6(2A):165-74. doi: 10.1016/s1083-8791(00)70039-5. Biol Blood Marrow Transplant. 2000. PMID: 10816024 Free article. Review.
Osteopenia and osteoporosis are common complications of bone marrow and peripheral blood stem cell transplantation. ...The spine and hip contain 50% to 75% trabecular bone and are most at risk for fracture after hematopoietic cell transplanta …
Osteopenia and osteoporosis are common complications of bone marrow and peripheral blood stem cell transplantation. ... …
Hormone replacement for osteoporosis in women with primary biliary cirrhosis.
Rudic JS, Poropat G, Krstic MN, Bjelakovic G, Gluud C. Rudic JS, et al. Cochrane Database Syst Rev. 2011 Dec 7;(12):CD009146. doi: 10.1002/14651858.CD009146.pub2. Cochrane Database Syst Rev. 2011. PMID: 22161447 Review.
BACKGROUND: Women with primary biliary cirrhosis often suffer from postmenopausal osteoporosis due to their age, or osteoporosis secondary to their liver disease, or treatments provided for their liver disease. Hormone replacement increases bone minera …
BACKGROUND: Women with primary biliary cirrhosis often suffer from postmenopausal osteoporosis due to their age, or osteopo …
Understanding Bone Damage After Kidney Transplantation: A Retrospective Monocentric Cross Sectional Analysis.
Gregorini M, Sileno G, Pattonieri EF, Corradetti V, Abelli M, Ticozzelli E, Scudeller L, Grignano MA, Esposito P, Bogliolo L, Giacomoni A, Rampino T. Gregorini M, et al. Transplant Proc. 2017 May;49(4):650-657. doi: 10.1016/j.transproceed.2017.02.023. Transplant Proc. 2017. PMID: 28457365
BACKGROUND: Kidney transplantation (KT) immunosuppression may induce bone tissue damage with bone mineral density (BMD) loss increasing bone fractures risk. ...PATIENTS AND METHODS: We designed an observational retrospective cohort study to eval …
BACKGROUND: Kidney transplantation (KT) immunosuppression may induce bone tissue damage with bone mineral density (BMD) …
23 results